Is This California Biopharma Co. In the Right Place at the Right Time?Roth MKM Analyst Dr. Jonathan Aschoff highlighted @GT_Biopharma's development of unique precision therapeutic agents using camelid-derived nanobodies.

$GTBP #biotechstocks
#GTBP #biotechstocks